Research Article

Identification of Prognostic Biomarkers of Glioblastoma Based on Multidatabase Integration and Its Correlation with Immune-Infiltration Cells

Table 4

Correlation analysis between TIMP1 and related genes and markers of immune cells in TIMER.

DescriptionGene markersGBM
NonePurity
CorPCorP

CD8+ T cellCD8A0.0930.251−0.0090.915
CD8B0.1680.0380.0690.420
T cell (general)CD3D0.2750.0880.308
CD3E0.2660.1210.160
CD20.2730.0920.285
B cellCD190.0430.600−0.0260.760
CD79 A−0.0370.654−0.0870.313
MonocyteCD860.3130.1110.198
CSF1R0.3590.1660.053
TAMCCL20.5790.490
CD680.4060.2100.014
IL100.3970.2140.012
Macrophage M1NOS20.1850.0220.266
IRF50.232−0.0050.954
PTGS20.4210.330
Macrophage M2CD1630.6390.556
VSIG40.4700.316
MS4A4A0.4980.380
NeutrophilsCEACAM8−0.0490.549−0.0860.315
ITGAM0.4470.279
CCR70.2750.1490.081
Natural killer cellKIR2DL1−0.0070.929−0.0370.668
KIR2DL3−0.0200.803−0.0830.335
KIR2DL40.1400.0830.0720.401
KIR3DL10.0360.6560.0230.793
KIR3DL20.1150.1580.1150.180
KIR3DL30.0340.675−0.0070.935
KIR2DS40.1740.0320.1360.112
Dendritic cellHLA-DPB10.3160.1750.041
HLA-DQB10.2410.1020.234
HLA-DRA0.3390.1670.051
HLA-DPA10.2230.1000.245
TregSTAT5B−0.226−0.1320.124
TGFB10.4110.268

 < 0.01;  < 0.001;  < 0.0001.